The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((R)-3-Amino-3-(4-((2-(2-methoxyethyl)quinolin-4-yl)methoxy)phenyl)-2-oxopyrrolidin-1-yl)-Nhydroxy-4-methylpentanamide ID: ALA3221864
PubChem CID: 86291010
Max Phase: Preclinical
Molecular Formula: C29H36N4O5
Molecular Weight: 520.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COCCc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1
Standard InChI: InChI=1S/C29H36N4O5/c1-19(2)16-26(27(34)32-36)33-14-13-29(30,28(33)35)21-8-10-23(11-9-21)38-18-20-17-22(12-15-37-3)31-25-7-5-4-6-24(20)25/h4-11,17,19,26,36H,12-16,18,30H2,1-3H3,(H,32,34)/t26-,29-/m1/s1
Standard InChI Key: OKHKINWJYOOKOF-GGXMVOPNSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
12.2889 -5.7718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6992 -5.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5060 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5935 -6.0494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8409 -6.3817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3627 -4.3022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3310 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7455 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5705 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9810 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5705 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7455 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8102 -5.2290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2206 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6956 -5.9418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2852 -6.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -6.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0456 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0456 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -3.7992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2852 -3.7992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6956 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2852 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1725 -6.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4684 -5.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9455 -5.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1307 -5.3436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8348 -6.1131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6120 -4.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3452 -6.7607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7004 -7.2792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4011 -8.0616 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7046 -7.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2861 -8.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7054 -8.8307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2869 -9.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5935 -4.4087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
2 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
13 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
15 24 1 0
19 24 1 0
14 18 1 0
10 13 1 0
3 7 1 0
25 26 1 0
26 27 1 1
27 28 1 0
28 29 1 0
28 30 1 0
1 26 1 0
25 31 2 0
25 32 1 0
32 33 1 0
16 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
3 38 1 1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 520.63Molecular Weight (Monoisotopic): 520.2686AlogP: 3.31#Rotatable Bonds: 11Polar Surface Area: 127.01Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.74CX Basic pKa: 7.46CX LogP: 2.62CX LogD: 2.44Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.37
References 1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P. (2011) Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors, 2 (10): [10.1039/C0MD00261E ]